Modified microplex vector enhances transfection of cells in culture while maintaining tumor-selective gene delivery in-vivo

Crispin Dass, Mark Burton

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

A non-commercial liposome (dimethyl dioctadecyl ammonium bromide:dioleoyl phosphatidylethanolamine) was compared with a commercial variety (Lipofectamine) for transfection of cultured rat adenocarcinoma cells and in an in-vivo kidney tumour model. Transfection of the cells in culture and in tumours in-vivo was variable with both types of liposomes. A high-dose microplex (lipoplex-microsphere) vector enhanced liposome-mediated transfection of cells in culture. When these high-dose microplexes were tested in-vivo, they were better than both microspherical and liposomal delivery modes in terms of transgene expression levels and the tumour-to-normal tissue ratio of gene delivery. Microplexes have been demonstrated to be capable of not only selective delivery of plasmids to solid tumours, but also of increasing transfection in cell culture, a finding that may be used in ex-vivo transfection studies. It is hypothesized that microspheres anchored the combination vector closer to the cultured cells, allowing attached liposomes to gain easier access into cells. In-vivo, microspheres permitted the microplexes to selectively deliver their genetic payload within the tumour tissue, from where the action of cationic liposomes on cellular membranes facilitated increased access of plasmids into the cytosol of target cells.
Original languageEnglish
Pages (from-to)19-25
Number of pages7
JournalJournal of Pharmacy and Pharmacology
Volume55
Issue number1
DOIs
Publication statusPublished - 2003

Fingerprint Dive into the research topics of 'Modified microplex vector enhances transfection of cells in culture while maintaining tumor-selective gene delivery in-vivo'. Together they form a unique fingerprint.

  • Cite this